China Medicine Corporation
CHME · OTC
9/30/2010 | 6/30/2010 | 3/31/2010 | 12/31/2009 | |
|---|---|---|---|---|
| Market Cap | $45,084 | $52,963 | $65,006 | $65,647 |
| - Cash | $7,854 | $9,004 | $11,087 | $472 |
| + Debt | $3,201 | $4,873 | $11,413 | $9,506 |
| Enterprise Value | $40,431 | $48,832 | $65,332 | $74,681 |
| Revenue | $17,550 | $17,190 | $10,572 | $20,442 |
| % Growth | 2.1% | 62.6% | -48.3% | – |
| Gross Profit | $5,804 | $6,107 | $3,247 | $6,842 |
| % Margin | 33.1% | 35.5% | 30.7% | 33.5% |
| EBITDA | $2,910 | $4,256 | $1,709 | $4,532 |
| % Margin | 16.6% | 24.8% | 16.2% | 22.2% |
| Net Income | $2,223 | $4,103 | $1,798 | -$2,095 |
| % Margin | 12.7% | 23.9% | 17% | -10.2% |
| EPS Diluted | 0.06 | 0.1 | -0.23 | -0.14 |
| % Growth | -40% | 143.5% | -64.3% | – |
| Operating Cash Flow | -$347 | -$3,506 | $1,429 | $13,431 |
| Capital Expenditures | -$4,435 | -$108 | -$64 | $31 |
| Free Cash Flow | -$4,782 | -$3,614 | $1,365 | $13,462 |